DE69532889D1 - Interleukin-5-spezifische rekombinante antikörper - Google Patents
Interleukin-5-spezifische rekombinante antikörperInfo
- Publication number
- DE69532889D1 DE69532889D1 DE69532889T DE69532889T DE69532889D1 DE 69532889 D1 DE69532889 D1 DE 69532889D1 DE 69532889 T DE69532889 T DE 69532889T DE 69532889 T DE69532889 T DE 69532889T DE 69532889 D1 DE69532889 D1 DE 69532889D1
- Authority
- DE
- Germany
- Prior art keywords
- interleukin
- recombinant antibodies
- specific recombinant
- specific
- heavy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9412230A GB9412230D0 (en) | 1994-06-17 | 1994-06-17 | Interleukin-5 specific recombiant antibodies |
GB9412230 | 1994-06-17 | ||
PCT/GB1995/001411 WO1995035375A1 (en) | 1994-06-17 | 1995-06-16 | Interleukin-5 specific recombinant antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69532889D1 true DE69532889D1 (de) | 2004-05-19 |
DE69532889T2 DE69532889T2 (de) | 2005-03-10 |
Family
ID=10756925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69532889T Expired - Lifetime DE69532889T2 (de) | 1994-06-17 | 1995-06-16 | Interleukin-5-spezifische rekombinante antikörper |
Country Status (18)
Country | Link |
---|---|
US (3) | US5998586A (de) |
EP (1) | EP0765392B1 (de) |
JP (1) | JP3973682B2 (de) |
AT (1) | ATE264389T1 (de) |
AU (1) | AU694783B2 (de) |
CA (1) | CA2192543C (de) |
CZ (1) | CZ292295B6 (de) |
DE (1) | DE69532889T2 (de) |
ES (1) | ES2218546T3 (de) |
FI (1) | FI965032A (de) |
GB (1) | GB9412230D0 (de) |
HU (1) | HU221641B1 (de) |
IL (1) | IL114179A (de) |
NO (1) | NO964808L (de) |
NZ (1) | NZ287927A (de) |
SK (1) | SK282625B6 (de) |
WO (1) | WO1995035375A1 (de) |
ZA (1) | ZA954990B (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39548E1 (en) | 1994-06-17 | 2007-04-03 | Celltech R&D Limited | Interleukin-5 specific recombinant antibodies |
GB9412230D0 (en) * | 1994-06-17 | 1994-08-10 | Celltech Ltd | Interleukin-5 specific recombiant antibodies |
JP2001523083A (ja) * | 1994-12-23 | 2001-11-20 | スミスクライン・ビーチャム・コーポレイション | Il−5により媒介される疾病の治療に有用な組み換えil−5アンタゴニスト |
US5693323A (en) * | 1994-12-23 | 1997-12-02 | Smithkline Beecham Corporation | Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
US7399837B2 (en) | 1995-12-22 | 2008-07-15 | Smithkline Beecham Corporation | Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
AU777952B2 (en) | 1999-04-23 | 2004-11-04 | Pharmexa A/S | Method for down-regulating IL5 activity |
MY157173A (en) | 2006-05-25 | 2016-05-13 | Glaxo Group Ltd | Modified humanised anti-interleukin-18 |
EP2274009B1 (de) | 2008-03-28 | 2013-11-13 | GlaxoSmithKline LLC | Behandlungsverfahren |
EP4083072A1 (de) * | 2008-10-06 | 2022-11-02 | Minerva Biotechnologies Corporation | Muc1*-antikörper |
EP3578205A1 (de) | 2010-08-06 | 2019-12-11 | ModernaTX, Inc. | Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung |
WO2012045082A2 (en) | 2010-10-01 | 2012-04-05 | Jason Schrum | Engineered nucleic acids and methods of use thereof |
ES2720136T3 (es) * | 2010-12-22 | 2019-07-18 | Teva Pharmaceuticals Australia Pty Ltd | Anticuerpo modificado con semivida mejorada |
AU2012236099A1 (en) | 2011-03-31 | 2013-10-03 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
EP3682905B1 (de) | 2011-10-03 | 2021-12-01 | ModernaTX, Inc. | Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon |
DK2791160T3 (da) | 2011-12-16 | 2022-05-30 | Modernatx Inc | Modificerede mrna-sammensætninger |
DE18200782T1 (de) | 2012-04-02 | 2021-10-21 | Modernatx, Inc. | Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen |
US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
US9878056B2 (en) | 2012-04-02 | 2018-01-30 | Modernatx, Inc. | Modified polynucleotides for the production of cosmetic proteins and peptides |
US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
HRP20220607T1 (hr) | 2012-11-26 | 2022-06-24 | Modernatx, Inc. | Terminalno modificirana rna |
EP2938359A4 (de) * | 2012-12-26 | 2016-10-12 | Oncosynergy Inc | Anti-integrin-beta1-antikörperzusammensetzungen und verfahren zur verwendung davon |
US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
WO2015048744A2 (en) | 2013-09-30 | 2015-04-02 | Moderna Therapeutics, Inc. | Polynucleotides encoding immune modulating polypeptides |
EP3052521A1 (de) | 2013-10-03 | 2016-08-10 | Moderna Therapeutics, Inc. | Polynukleotide zur codierung von low-density-lipoprotein-rezeptor |
EP3160479A4 (de) | 2014-06-30 | 2018-07-04 | Academia Sinica | Antagonisten für den interleukin-17 rezeptor b (il-17rb) und seinem liganden il-17b zur krebstherapie |
WO2016130726A1 (en) | 2015-02-10 | 2016-08-18 | Minerva Biotechnologies Corporation | Humanized anti-muc1* antibodies |
WO2017033121A1 (en) | 2015-08-24 | 2017-03-02 | Glaxosmithkline Intellectual Property (No. 2) Limited | Biopharmaceutical compositions |
JP7295038B2 (ja) | 2017-06-06 | 2023-06-20 | グラクソスミスクライン エルエルシー | 小児患者のための生物薬剤組成物及び方法 |
BR112020005766A2 (pt) | 2017-09-29 | 2020-10-13 | Jiangsu Hengrui Medicine Co., Ltd. | anticorpo il-5, fragmento de ligação ao antígeno do mesmo, e aplicação médica do mesmo |
CN109942706A (zh) * | 2017-12-21 | 2019-06-28 | 三生国健药业(上海)股份有限公司 | 结合人il-5的单克隆抗体、其制备方法和用途 |
US20220010008A1 (en) * | 2018-12-12 | 2022-01-13 | Shanghai Pharmaexplorer Co., Ltd. | Anti-human interleukin 5(il-5) monoclonal antibody and use thereof |
MX2021011530A (es) | 2019-03-29 | 2021-10-22 | Jiangsu Hengrui Medicine Co | Composicion farmaceutica que contiene anticuerpos contra il-5 y su uso. |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8308235D0 (en) * | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
GB8607679D0 (en) * | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
ATE98872T1 (de) * | 1988-11-03 | 1994-01-15 | Schering Corp | Antagonist fuer interleukin-5 zur verhuetung oder verminderung von eosinophilie. |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
IL162181A (en) * | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
GB8928874D0 (en) * | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
WO1992008474A2 (en) * | 1990-11-20 | 1992-05-29 | The National Heart & Lung Institute | Treatment of lung diseases |
KR0150060B1 (ko) * | 1992-02-06 | 1998-08-17 | 에릭 에스. 딕커 | 사람 인터루킨-5에 대한 인간화 모노클로날 항체의 고안, 클로닝 및 발현 |
JPH07502901A (ja) * | 1992-02-19 | 1995-03-30 | シェリング・コーポレーション | ヒトインターロイキン−4に対するヒト化モノクローナル抗体のクローニング及び発現 |
GB9412230D0 (en) * | 1994-06-17 | 1994-08-10 | Celltech Ltd | Interleukin-5 specific recombiant antibodies |
-
1994
- 1994-06-17 GB GB9412230A patent/GB9412230D0/en active Pending
-
1995
- 1995-06-06 US US08/470,139 patent/US5998586A/en not_active Ceased
- 1995-06-15 IL IL11417995A patent/IL114179A/xx not_active IP Right Cessation
- 1995-06-15 ZA ZA954990A patent/ZA954990B/xx unknown
- 1995-06-16 JP JP50181796A patent/JP3973682B2/ja not_active Expired - Lifetime
- 1995-06-16 AT AT95921931T patent/ATE264389T1/de not_active IP Right Cessation
- 1995-06-16 HU HU9603183A patent/HU221641B1/hu not_active IP Right Cessation
- 1995-06-16 SK SK1600-96A patent/SK282625B6/sk unknown
- 1995-06-16 WO PCT/GB1995/001411 patent/WO1995035375A1/en active IP Right Grant
- 1995-06-16 NZ NZ287927A patent/NZ287927A/en not_active IP Right Cessation
- 1995-06-16 AU AU26803/95A patent/AU694783B2/en not_active Ceased
- 1995-06-16 CZ CZ19963712A patent/CZ292295B6/cs not_active IP Right Cessation
- 1995-06-16 ES ES95921931T patent/ES2218546T3/es not_active Expired - Lifetime
- 1995-06-16 CA CA002192543A patent/CA2192543C/en not_active Expired - Lifetime
- 1995-06-16 DE DE69532889T patent/DE69532889T2/de not_active Expired - Lifetime
- 1995-06-16 EP EP95921931A patent/EP0765392B1/de not_active Expired - Lifetime
-
1996
- 1996-11-13 NO NO964808A patent/NO964808L/no unknown
- 1996-12-16 FI FI965032A patent/FI965032A/fi not_active Application Discontinuation
-
1999
- 1999-07-02 US US09/347,061 patent/US6316227B1/en not_active Expired - Lifetime
-
2001
- 2001-05-15 US US09/855,271 patent/US6734286B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO964808L (no) | 1997-02-17 |
US6734286B2 (en) | 2004-05-11 |
WO1995035375A1 (en) | 1995-12-28 |
FI965032A0 (fi) | 1996-12-16 |
US6316227B1 (en) | 2001-11-13 |
SK160096A3 (en) | 1997-06-04 |
CA2192543A1 (en) | 1995-12-28 |
EP0765392A1 (de) | 1997-04-02 |
US20020042089A1 (en) | 2002-04-11 |
JPH10501697A (ja) | 1998-02-17 |
GB9412230D0 (en) | 1994-08-10 |
AU2680395A (en) | 1996-01-15 |
AU694783B2 (en) | 1998-07-30 |
DE69532889T2 (de) | 2005-03-10 |
ZA954990B (en) | 1996-12-17 |
CZ371296A3 (cs) | 1998-05-13 |
HU9603183D0 (en) | 1997-01-28 |
IL114179A (en) | 2001-08-26 |
CZ292295B6 (cs) | 2003-08-13 |
SK282625B6 (sk) | 2002-10-08 |
FI965032A (fi) | 1996-12-16 |
JP3973682B2 (ja) | 2007-09-12 |
EP0765392B1 (de) | 2004-04-14 |
IL114179A0 (en) | 1995-10-31 |
ES2218546T3 (es) | 2004-11-16 |
NZ287927A (en) | 1998-07-28 |
NO964808D0 (no) | 1996-11-13 |
HU221641B1 (hu) | 2002-12-28 |
HUT76672A (en) | 1997-10-28 |
ATE264389T1 (de) | 2004-04-15 |
US5998586A (en) | 1999-12-07 |
CA2192543C (en) | 2008-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69532889D1 (de) | Interleukin-5-spezifische rekombinante antikörper | |
FI956112A (fi) | Monoklonaalinen anti- V-integriinivasta-aine | |
DE69430060D1 (de) | Antikörper von rapamycinen mit offenem ring | |
DK0812333T3 (da) | Bispecifikt antistof, som er effektivt til behandling af B-cellelymfom og cellelinie | |
PT778891E (pt) | Anticorpo monoclonal recombinante anti-rhesus d (d7c2) | |
DE68914244D1 (de) | Monoklonaler Antikörper. | |
NL300163I1 (nl) | Vermenselijkte anti-CD1 11a-antilichamen. | |
ES2106195T3 (es) | Anticuerpo igg aglicosilado anti cd3. | |
FI20070170A (fi) | Immunoglobuliinit, joista puuttuvat kevyet ketjut | |
AU628948B2 (en) | Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof | |
DE69828154D1 (de) | Anti-alphavbeta3 humanizierte monoklonale antikörper | |
DE69738312D1 (de) | Hepatitis b monoklonale antikörper | |
TR199800517A3 (tr) | Hümanize anti-hümen fas antikor. | |
BR9509902A (pt) | Fragmentos de anticorpos monoclonais apresentando atividade imunosupressante | |
DE59608073D1 (de) | Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid | |
NO890116L (no) | Monoklonale antistoffer. | |
DE69023717D1 (de) | Monoklonaler Antikörper. | |
DE69020315D1 (de) | Monoklonaler antikörper gegen c-reaktives protein. | |
ITRM920223A0 (it) | Anticorpi monoclonali anti-idiopici diretti contro anticorpi anti-tnf. | |
NO985281D0 (no) | Monoklonalt antihumant MP52-antistoff | |
DE69324928D1 (de) | Monoklonaler antikörper | |
FI960566A0 (fi) | Monoklonaalinen vasta-aine, joka tunnistaa välisolun pinta-antigeenin | |
DE68916088D1 (de) | Anti-CPBII-monoklonaler Antikörper. | |
DE69320192D1 (de) | Monoklonaler antikörper gegen den extravillösen trophoblast | |
DK0778891T3 (da) | Rekombinant monoklonalt antistof mod rhesus D (D7C2) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |